Ironic considering SSRN is owned by Elsevier, which is renown for trying to limit/control information for profit.
It even published fake journals to spread "fake news" ( aka ads ) for the pharmaceutical industry.
"The company has fought legislation designed to open up academic research, offered scholars money to file positive reviews, sued libraries for oversharing, and allegedly published fake journals on behalf of the pharmaceuticals industry."
It even published fake journals to spread "fake news" ( aka ads ) for the pharmaceutical industry.
"The company has fought legislation designed to open up academic research, offered scholars money to file positive reviews, sued libraries for oversharing, and allegedly published fake journals on behalf of the pharmaceuticals industry."
https://www.newyorker.com/tech/annals-of-technology/when-the...